SCHEMBL8428468

SCHEMBL8428468

CCC1=C(Cc2nnn[nH]2)c2cc(OC)ccc2C1=Cc1ccc(Cl)cc1

nearest known ligand 0.39

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
MEN1 O00255 5/20 0.39
KMT2A Q03164 5/20 0.39
MAPT P10636 3/20 0.39
ALOX12 P18054 3/20 0.39
NPSR1 Q6W5P4 2/20 0.39
ALOX15 P16050 2/20 0.39
NPC1 O15118 1/20 0.35
RAB9A P51151 1/20 0.35
PSEN1 P49768 4/20 0.34
PSEN2 P49810 4/20 0.34
APH1B Q8WW43 4/20 0.34
NCSTN Q92542 4/20 0.34
APH1A Q96BI3 4/20 0.34
PSENEN Q9NZ42 4/20 0.34
GAA P10253 2/20 0.34
HPGD P15428 2/20 0.34
RXRA P19793 2/20 0.34
LCK P06239 1/20 0.34
KDM4E B2RXH2 1/20 0.34
CYP1A2 P05177 1/20 0.34

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL8428373 0.89 RXRA (0.39) MEN1KMT2AMAPTALOX12NPSR1
SCHEMBL8428338 0.84 RXRA (0.36) MEN1KMT2ARXRALRRK2
SCHEMBL8432133 0.79 PPARG (0.45) MEN1KMT2AMAPTHPGDRXRA
SCHEMBL8432051 0.78 PPARG (0.41) MEN1KMT2AMAPTALOX12NPSR1
SCHEMBL8430200 0.78 MAOB (0.40) MEN1KMT2AMAPTRXRALCK
SCHEMBL8428469 0.77 RXRA (0.49) MAPTPSEN1PSEN2APH1BNCSTN
SCHEMBL8428313 0.77 RXRA (0.46) RXRALCK
SCHEMBL8430717 0.76 RXRA (0.39) MEN1KMT2AMAPTNPSR1RAB9A
SCHEMBL8430782 0.75 RXRA (0.38) MEN1KMT2AMAPTNPSR1PSEN1
SCHEMBL8428613 0.74 RXRA (0.37) MEN1KMT2AMAPTNPSR1PSEN1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-5965619-A ADMINISTERING AN INDENE DERIVATIVE OF GIVEN FORMULA, SUCH AS 1-(2,4,6-TRIMETHOXYBENZYLIDENE)-5-DIMETHYLAMINO-2-METHYL-3-INDENYL ACETIC ACID, TO TREAT PRECANCEROUS LESIONS SUCH AS COLONIC ADENOMATOUS POLYPS; SIDE EFFECT REDUCTION CELL PATHWAYS INC. (US) 1999-10-12 US disclosed